FDA Inspection 1264264 — Catalent Indiana, LLC

Catalent Indiana, LLC — FEI 3005949964

The FDA completed an inspection of Catalent Indiana, LLC on July 14, 2025 in Bloomington, IN. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
July 14, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Bloomington, IN (United States)